Suchergebnisse - (Person:"Guo, Ensong")

PubPharm (9)

1

A reactive oxygen species scoring system predicts cisplatin sensitivity and prognosis in ovarian cancer patients

enthalten in: BMC cancer | 2019

von Sun, C. | Guo, E. | Zhou, B. | +13

ErratumIn: BMC Cancer. 2020 Mar 12;20(1):210. - PMID 32164614

2

Clarithromycin synergizes with cisplatin to inhibit ovarian cancer growth in vitro and in vivo

enthalten in: Journal of ovarian research | 2019

von Zhou, B. | Xia, M. | Wang, B. | +7

3

The biodiversity Composition of Microbiome in Ovarian Carcinoma Patients

enthalten in: Scientific reports | 2019

von Zhou, B. | Sun, C. | Huang, J. | +14

4

Overexpressed miR-9 promotes tumor metastasis via targeting E-cadherin in serous ovarian cancer

enthalten in: Frontiers of medicine | 2017

von Zhou, B. | Xu, H. | Xia, M. | +15

5

Role of Dicer as a prognostic predictor for survival in cancer patients : a systematic review with a meta-analysis

enthalten in: Oncotarget | 2016

von Shan, W. | Sun, C. | Zhou, B. | +9

6

Blockage of glutaminolysis enhances the sensitivity of ovarian cancer cells to PI3K/mTOR inhibition involvement of STAT3 signaling

enthalten in: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine | 2016

von Guo, L. | Zhou, B. | Liu, Z. | +7

7

KCNN4 and S100A14 act as predictors of recurrence in optimally debulked patients with serous ovarian cancer

enthalten in: Oncotarget | 2016

von Zhao, H. | Guo, E. | Hu, T. | +16

8

Cisplatin-induced CCL5 secretion from CAFs promotes cisplatin-resistance in ovarian cancer via regulation of the STAT3 and PI3K/Akt signaling pathways

enthalten in: International journal of oncology | 2016

von Zhou, B. | Sun, C. | Li, N. | +10

9

HSP27 Knockdown Increases Cytoplasmic p21 and Cisplatin Sensitivity in Ovarian Carcinoma Cells

enthalten in: Oncology research | 2016

von Lu, H. | Sun, C. | Zhou, T. | +11

1
[1]